AddLife - Public Comps and Valuation Multiples

AddLife Overview

About AddLife

AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

Founded

1906

HQ

Employees

2.3K+

Website

add.life

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $1.0B

LTM EBITDA $155M

EV

$2.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

AddLife Financials

AddLife has a last 12-month revenue of $1.0B and a last 12-month EBITDA of $155M.

In the most recent fiscal year, AddLife achieved revenue of $1.0B and an EBITDA of $151M.

AddLife expects next 12-month revenue of XXX and NTM EBITDA of XXX

See AddLife valuation multiples based on analyst estimates

AddLife P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$962M	$1.0B	XXX	XXX	XXX
Gross Profit	$340M	$357M	XXX	XXX	XXX
Gross Margin	35%	35%	XXX	XXX	XXX
EBITDA	$152M	$151M	XXX	XXX	XXX
EBITDA Margin	16%	15%	XXX	XXX	XXX
Net Profit	$47.7M	$18.9M	XXX	XXX	XXX
Net Margin	5%	2%	XXX	XXX	XXX
Net Debt	$482M	$448M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

AddLife Stock Performance

As of April 15, 2025, AddLife's stock price is SEK 149 (or $15).

AddLife has current market cap of SEK 18.1B (or $1.8B), and EV of SEK 22.9B (or $2.3B).

See AddLife trading valuation data

AddLife Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$2.3B	$1.8B	XXX	XXX	XXX	XXX	$0.56

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

AddLife Valuation Multiples

As of April 15, 2025, AddLife has market cap of $1.8B and EV of $2.3B.

AddLife's trades at 2.2x LTM EV/Revenue multiple, and 14.6x LTM EBITDA.

Analysts estimate AddLife's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for AddLife and 10K+ public comps

AddLife Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$2.3B	XXX	XXX	XXX
EV/Revenue	2.2x	XXX	XXX	XXX
EV/EBITDA	15.1x	XXX	XXX	XXX
P/E	71.9x	XXX	XXX	XXX
P/E/Growth	1.7x	XXX	XXX	XXX
EV/FCF	28.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get AddLife Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

AddLife Valuation Multiples

AddLife's NTM/LTM revenue growth is 5%

AddLife's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, AddLife's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate AddLife's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for AddLife and other 10K+ public comps

AddLife Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	6%	XXX	XXX	XXX	XXX
EBITDA Margin	15%	XXX	XXX	XXX	XXX
EBITDA Growth	-1%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	20%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.5M	XXX	XXX	XXX	XXX
Opex per Employee	$0.1M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	24%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	6%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	1%	XXX	XXX	XXX	XXX
Opex to Revenue	31%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry